The HRC is pleased to announce the funding of two additional research projects that will aim to contribute to the goal of improving and ultimately ensuring breast cancer survival in New Zealand.
The following list of successful applicants includes the named principal investigator only.
Professor Parry Guilford
University of Otago
Synthetic lethal targeting of lobular breast cancer
24 months, $199,792 (funded by the HRC, Breast Cancer Cure and The New Zealand Breast Cancer Foundation)
Dr Annette Lasham
The University of Auckland
Developing a molecular "fingerprint" as a non-invasive screen for breast cancer
24 months, $196,183 (funded by the HRC and Breast Cancer Cure)
Read a lay summary of this project.
These projects were originally submitted to the Breast Cancer Research in New Zealand initiative, which is a joint funding partnership between Breast Cancer Cure, The New Zealand Breast Cancer Foundation and the HRC.
Read the announcement of the three research projects initially funded through the Breast Cancer Research Partnership.